The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Apr. 28, 2021
Applicant:

Arrinex, Inc., Redwood City, CA (US);

Inventors:

Vahid Saadat, Atherton, CA (US);

William Jason Fox, San Mateo, CA (US);

Mojgan Saadat, Atherton, CA (US);

Assignee:

Arrinex, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/02 (2006.01); A61B 17/24 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/02 (2013.01); A61B 17/24 (2013.01); A61B 2017/003 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/00946 (2013.01); A61B 2017/00991 (2013.01); A61B 2018/00196 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0231 (2013.01);
Abstract

The invention disclosed here generally relates to devices that can modify a property of a nerve. Specifically, the subject invention is contemplated to modify the posterior nasal nerve signal conduction in such a way so as to reduce the signals transmitted to the nasal cavity. Reduction or interruption of the nerve signals results in the reduction of the distal organ activity. In particular, embodiments of the present invention allow for increased lateral contact or apposition of the target tissue region having at least one posterior nasal nerve with the end effector surface by lateral and/or longitudinal translation of the end effector relative to the surgical probe shaft. This improved lateral surface contact has several benefits, including improved patient outcomes and patient safety as the end effector is adequately in contact with target tissue for subsequent ablation therapy.


Find Patent Forward Citations

Loading…